HER2 Mutations Present Unique Challenges in NSCLC

In Brief for Nov. 9, 2022

Targeted Therapies Expanding for MET Dysregulation in NSCLC

Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration

Tobacco Control Committee Chair Discusses Recent Legislative, Research Developments

Meeting News for Nov. 23, 2022

Regulatory News for Nov. 23, 2022

Guideline-Concordant Surgery, Adjuvant Therapy, and the Promise of Curative-Intent Lung Cancer Surgery: What Are We Up Against?

New Screening Approach Needed to Detect Lung Cancer in Patients who Never Smoked

Palliative Care Benefits Vary Depending on Providers, Timing

In Brief for Dec. 7, 2022

From the Editor: Looking Back on 2022